About Verantos
Verantos is a company based in Menlo Park (United States) founded in 2009. The company has 29 employees as of April 05, 2024. Verantos offers products and services including Pragmatic Registry Platform and Research Network. Verantos operates in a competitive market with competitors including Indegene, Centivo, iMedX, Omega Healthcare and IntegriChain, among others.
- Headquarter Menlo Park, United States
- Employees 29 as on 05 Apr, 2024
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Verantos India Private Limited
- Date of Incorporation 12 Sep, 2019
- Jurisdiction Pune City, Maharashtra, India
-
Annual Revenue
$959.51 K (USD)60.21as on Mar 31, 2023
-
Net Profit
$299.54 K (USD)560.48as on Mar 31, 2023
-
EBITDA
$153.32 K (USD)70.18as on Mar 31, 2023
-
Latest Funding Round
$1.5 M (USD), Grant
Jun 01, 2018
-
Investors
NIH
& 1 more
-
Employee Count
29
as on Apr 05, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Verantos
Verantos offers a comprehensive portfolio of products and services, including Pragmatic Registry Platform and Research Network.
Generates disease-specific registries from real-world data for evidence.
Facilitates research and evidence sharing in life sciences domains.
People of Verantos
Unlock access to complete
Funding Insights of Verantos
Investors in Verantos
Verantos has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include NIH and National Science Foundation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Drug discovery services are provided to the biopharma sector.
|
Locked | Locked | Locked | |
|
A government-backed foundation providing seed-stage investments to support small businesses.
|
Locked | Locked | Locked |
Investor details for Verantos
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Verantos
Investment portfolio details for Verantos
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Verantos
Detailed financials for Verantos
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Verantos Comparisons
Peer comparison for Verantos
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Verantos
Verantos operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Indegene, Centivo, iMedX, Omega Healthcare and IntegriChain, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Suite solutions are provided for payers and healthcare providers.
|
|
| Locked | Locked | Locked |
Provider of self funded health plan
|
|
| Locked | Locked | Locked |
Revenue cycle management platform is provided to healthcare providers.
|
|
| Locked | Locked | Locked |
Healthcare outsourcing services are provided to various sectors.
|
|
| Locked | Locked | Locked |
Inventory, order and customer relationship management solution for life science suppliers.
|
|
| Locked | Locked | Locked |
Specialty medicines are supplied via clinical trials and access programs.
|
Detailed competitors of Verantos
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Verantos
Complete news archive for Verantos
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Verantos
Verantos was founded in 2009 and raised its 1st funding round 9 years after it was founded.
Verantos is headquartered in Menlo Park, United States. It is registered at Menlo Park, California, United States.
Dan Riskin is the current CEO of Verantos.
As of Apr 05, 2024, the latest employee count at Verantos is 29.
Annual revenue of Verantos is $959.51K as on Mar 31, 2023.
Verantos was founded in 2009 and is based in Menlo Park, United States. Services focused on data validation and regulatory compliance are delivered to the biopharma sector. Operations involve ensuring data integrity and adherence to industry standards for pharmaceutical and biotechnology firms. Leadership is provided by CEO Dan Riskin, with activities centered on supporting validation processes across the sector.
Verantos's top competitors include Indegene, Centivo and Access Healthcare.
Verantos offers Pragmatic Registry Platform and Research Network.
Verantos has 2 investors. Key investors include NIH, and National Science Foundation.